Twenty of the twenty-two CMTs were ERα-positive, whereas two malignant tumors (i.e., intraductal papillary carcinoma, grade I; solid carcinoma, grade III) with TS ≤ 3 were considered to be ERα-negative. This evidence concerns the gene ESR1 and cancer.